Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Increased by Gerber Kawasaki Wealth & Investment Management

Gerber Kawasaki Wealth & Investment Management increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 99.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,576 shares of the medical equipment provider's stock after buying an additional 1,285 shares during the period. Gerber Kawasaki Wealth & Investment Management's holdings in Intuitive Surgical were worth $1,345,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. M.E. Allison & CO. Inc. purchased a new position in Intuitive Surgical during the fourth quarter worth approximately $449,000. Seilern Investment Management Ltd purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $82,517,000. Sycomore Asset Management raised its stake in shares of Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after acquiring an additional 4,079 shares during the period. Exome Asset Management LLC increased its stake in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock worth $3,649,000 after buying an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. increased its stake in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after buying an additional 525 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms recently issued reports on ISRG. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Barclays decreased their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Piper Sandler decreased their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Citigroup raised their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a report on Friday, January 24th. Finally, Bernstein Bank lifted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a report on Monday, January 27th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $598.95.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 188 shares of the firm's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the sale, the chief financial officer now directly owns 7,162 shares of the company's stock, valued at approximately $4,060,424.28. This represents a 2.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 30,913 shares of company stock valued at $15,981,143 in the last three months. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Up 0.2 %

NASDAQ ISRG traded up $0.91 on Wednesday, reaching $515.80. 1,650,105 shares of the stock traded hands, compared to its average volume of 1,619,216. The firm's fifty day simple moving average is $508.20 and its 200 day simple moving average is $533.13. The company has a market cap of $184.87 billion, a price-to-earnings ratio of 80.47, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12 month low of $367.39 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period last year, the company posted $1.50 EPS. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.